| Patient number | Age at diagnosis (years)/ Gender | Diagnosis, grade | Location | Primary/recurrent | Highest stage |
| 1 | 10.9/Male | Medulloblastoma, IV | Posterior fossa and Cervical-spine | Recurrent | M3 | 2 | 15.9/Male | NGGCT | Pineal | Primary | M0 | 3 | 0.9/Male | Medulloblastoma, IV | Posterior fossa | Primary | M0 | 4 | 17.3/Male | NGGCT | Pineal | Primary | M0 | 5 | 2.9/Female | Anaplastic Oligodendroglioma, III | Frontal, Left | Primary | M0 | 6 | 5.3/Male | Supratentorial PNET, IV | Cerebral, Left | Primary | M0 | 7 | 0.6/Male | Medulloblastoma, IV | Posterior fossa | Primary | M2 | 8 | 1.2/Female | Neurocytoma, II | Frontal, Right | Recurrent | M3 | 9 | 18.6/Male | NGGCT | Pineal | Recurrent | M3 | 10 | 4.4/Female | Supratentorial PNET, IV | Frontal, Left | Primary | M0 | 11 | 1.8/Male | Supratentorial PNET, IV | Frontal, Right | Primary | M0 | 12 | 2.2/Male | Anaplastic Ependymoma, III | Occipitoparietal, Left | Primary | M0 | 13 | 10.2/Female | Pineoblastoma, IV | Pineal | Recurrent | M2 | 14 | 0.4/Male | Medulloblastoma, IV | Posterior fossa | Primary | M3 | 15 | 2.4/Female | Medulloblastoma, IV | Brainstem | Primary | M0 | 16 | 2.1 /Female | Medulloblastoma, IV | Posterior fossa | Primary | M0 | 17 | 2.1/Male | Supratentorial PNET, IV | Frontal, Right | Primary | M2 | 18 | 1.7/Male | Medulloblastoma, IV | Posterior fossa | Primary | M2 |
|
|